Chromatography and Mass Spectrometry for Drug Quantification in Biological Fluids
This community develops and validates analytical methods to measure the concentration of pharmaceutical compounds, fatty acids, and other small molecules in human plasma, serum, and animal tissues. The work primarily serves pharmaceutical quality control, clinical therapeutic drug monitoring, and forensic toxicology.
The recurring technical focus is on liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) and high-performance liquid chromatography (HPLC). Titles frequently cite the simultaneous determination or quantification of specific drugs, such as losartan potassium, in dosage forms and biological samples. A significant portion of the research addresses method validation, isotope dilution, and the development of green analytical chemistry approaches to reduce environmental impact. While the core is pharmaceutical analysis, the community also includes work on fatty acid composition in dairy and biological fluids, and the separation of natural products using chiral stationary phases.
The largest share of this community's output is found in nitrogen research, accounting for 0.1% of all nitrogen-related papers, with 918 papers here. Sodium research follows with 0.3% of its element-specific output, comprising 813 papers.
The community comprises 16,658 papers, published predominantly in the Journal of Chromatography A, Journal of Chromatography B: Biomedical Sciences and Applications, and Analytical Chemistry.
Recent work continues to focus on the optimization of HPLC and mass spectrometry methods for therapeutic drug monitoring and the analysis of complex matrices like wine and dairy products. Specific recent studies include the determination of biogenic amines in wine, the analysis of fatty acid composition in dairy products, and the development of new stationary phases for food additive analysis.